Hsiou-Chi Liou

Hsiou-Chi Liou

ImmuneTarget, Inc

Affiliations

Weill Cornell Medicine

Technologies

Therapeutic

Indication

Allergy/Asthma

Autoimmune & Inflammation

Cardiovascular Disease

Drug Discovery

Fibrosis

Oncology

Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases.

Newsletter Signup

Corporate Supporters

Community Service Providers